<scp>ITGB3</scp> promotes cisplatin resistance in osteosarcoma tumors

Abstract

Our results will contribute to a better understanding of the function and mechanism of ITGB3 in osteosarcoma cisplatin resistance and provide a novel therapeutic target to decrease cisplatin resistance and tumor recurrence in osteosarcoma patients.